Dehydroevodiamine

Overview

Dehydroevodiamine is a major bioactive quinazoline alkaloid isolated from Evodiae Fructus , has an antiarrhythmic effect in guinea-pig ventricular myocytes. Dehydroevodiamine inhibits LPS-induced iNOS , COX-2 , prostaglandin E2 ( PGE2 ) and nuclear factor-kappa B ( NF-κB ) expression in murine macrophage cells.

Application

Products | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Respiratory Disease | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Musculoskeletal and Skin Disease | Products > Disease Areas > Pulmonary Disease | Products > Disease Areas > Autoimmune Disease | Products > Disease Areas > Arthritis | Products > Disease Areas > Breast Cancer | Products > Disease Areas > Pancreatic Cancer | Products > Disease Areas > Digestive System Cancer | Products > Disease Areas > Pain | Products > Disease Areas > Digestive System Inflammation | Products > Disease Areas > Lung Fibrosis | Products > Disease Areas > Rheumatoid Arthritis | Products > Disease Areas > Cancer | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Signaling Pathways > NF-κB | Products > Signaling Pathways > Immunology/Inflammation | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > NF-κB | Products > Signaling Pathways > COX | Products > Signaling Pathways > PGE synthase | Products > Signaling Pathways > NO Synthase

Product Information

• Catalog No.: HY-N2106
• CAS No.: 67909-49-3
• Molecular Formula: C19H15N3O
• Molecular Weight: 301.34
• Purity: 98.55%
• Storage: 4°C, protect from light * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
• Solubility: ≥ 1 mg/mL (3.32 mM); Clear solution
• Availability: In-stock

Source

Original product source